/
Other
Substance Abuse
12
Pipeline Programs↗
5
Active Trials↗
9
Companies Involved↗
Substance Abuse is an emerging landscape with 12 programs across 9 companies. The most active players are Otsuka.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical12
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
19
clinical trials
Completed14 · 74%
Recruiting3 · 16%
Active, not recruiting1 · 5%
Not yet recruiting1 · 5%
Clinical Trials
Trial Activity
19 trials
Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction
Recruiting·—·N/A·NCT03913819·1,000 enrolled
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
Completed·—·Phase 2·NCT00316303·236 enrolled
Depakote ER Therapy for Mania Comorbid With Substance Abuse
Completed·—·Phase 4·NCT00208195·20 enrolled
Treatment of Comorbid Depression and Substance Abuse in Young People
Completed·—·Phase 2·NCT00232284·60 enrolled
Contingency Management for Smoking in Substance Abusers
Completed·—·N/A·NCT00807742·340 enrolled
Abilify Therapy for Reducing Comorbid Substance Abuse
Completed·—·Phase 4·NCT00208169·30 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)